Using Absorption Simulation and Gastric pH Modulated Dog Model for Formulation Development To Overcome Achlorhydria Effect-Reference-Cited by-同舟云学术

Using Absorption Simulation and Gastric pH Modulated Dog Model for Formulation Development To Overcome Achlorhydria Effect

Published:2011-10-20 Issue:6 Volume:8 Page:2216-2223
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Mitra Amitava¹,Kesisoglou Filippos¹,Beauchamp Martyn,Zhu Wei¹,Chiti Fabio,Wu Yunhui¹

Affiliation:

1. Biopharmaceutics, Product Value Enhancement, Pharmaceutical Sciences and Clinical Supply, Merck Sharp & Dohme Corp., West Point, Pennsylvania, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp200062a

Reference18 articles.

1. Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy

2. Assessment of Gastric Acidity of Japanese Subjects over the Last 15 Years.

3. Systematic review: impaired drug absorption related to the co-administration of antisecretory therapy

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations;Drug Metabolism Reviews;2024-05-03

2. Effects of H2-Receptor Antagonists on the Exposure of Dacomitinib;Pharmaceutics;2024-01-17

3. Influence of N-protonation on electronic properties of acridine derivatives by quantum crystallography;RSC Advances;2024

4. Contribution of the Dynamic Intestinal Absorption Model (Diamod) to the Development of a Patient-Centric Drug Formulation;Molecular Pharmaceutics;2023-11-13

5. Determinant Factors for Passive Absorption of Drugs;Oral Bioavailability and Drug Delivery;2023-10-10